| Cancers | New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors 2.0 (STRATAGEM Special Issue, EU-COST CA17104) | Chiara Riganti M. Helena Vasconcelos Catherine Passirani | 15 September 2022 |
| Molecules | Single-Cell Proteomics—Development of Methods for Sample and Data Analyses | Goran Mitulović Thomas Mohr | 1 March 2023 |
| Biomedicines | 10th Anniversary of Biomedicines—Exploring the Genome, Transcriptome and Proteome Landscape in Diseases | Thomas MohrAlexander Tolios | 15 November 2022 |
| Biomedicines | Bioinformatics and Its Application in Biomedicine 2.0 | Thomas Mohr | 31 October 2022 |
| Scientific Reports Nature | Collection "Drug repurposing" | Maria Cristina De RosaAlfonso T. Garcia-SosaRituraj Purohit | 30 September 2022 |
| Biomedicines | Targeting Proteins - In-Silico, In-Vitro, and In-Vivo Evidence | Alexander ToliosThomas Mohr | 31 July 2022 |
| JOVE Methods Collections | Application Methods of Bioactive Natural Products | Patricia RijoVera M. S. IscaEpole N. NtungweMarcia Santos Filipe | |
| International Journal of Molecular Sciences (IJMS/MDPI) | Insights in New Biomarkers and Molecular Drug Targets in Hematological Neoplasias | Ana Cristina GonçalvesAna Bela Sarmento RibeiroRaquel Alves | 30 June 2022 |
| Frontiers in Physiology | Translational Research and Clinical Perspective on Circular RNA in Stem Cells | Ana Cristina GonçalvesSergio RutellaMafalda LaranjoAna Bela Sarmento Ribeiro
Topic Coordinator:Raquel Alves | 16 April 2022 |
| Pharmaceuticals | Multitarget Drug Discovery and Pharmacology | Óscar López | 15 April 2022 |
Frontiers in Pharmacology;
Frontiers in Oncology | Methods and Application in Pharmacology of Anti-Cancer Drugs: 2021 | Balaji KrishnamacharyAna Bela Sarmento Ribeiro | 23 February 2022 |
| Cancers | New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104) | Chiara Riganti M. Helena Vasconcelos Catherine Passirani | 31 January 2022 |
| Frontiers | Novel Therapeutic Approaches to Target Drug Resistant Tumors | Joanna Kopecka Chiara Riganti Konrad Kowalski | 31 January 2022 |
| Cancers | Tumor Microenvironment: A Key Piece in the Puzzle of Cancer Heterogeneity | Cyril Corbet Ivana Kurelac | 31 January 2022 |
| Journal of Molecular and Clinical Medicine | Targeting the tumor microenvironment for cancer treatment | Cristina Xavier | 31 December 2021 |
| Frontiers | Metallodrugs Induced Epithelial-Mesenchymal Transition and Multidrug Resistance in Cancer | Anamaria Brozovic Petra Heffeter Britta Stordal | 16 December 2021 |
| Pharmaceuticals | Anticancer Drugs 2021 | Mary J. Meegan Niamh M O’Boyle | 31 October 2021 |
| Molecules | Bioactive Molecules as Multidrug Resistance Modulators | Cristina Xavier M. Helena Vasconcelos | 31 October 2021 |
| Molecules | Nitric Oxide Donors for Biomedical Applications | Roberta Fruttero Elena Gazzano Federica Sodano | 30 September 2021 |
| Frontiers | The Role of Drug Resistance Mechanisms in Tumor Adaptation to Oxidative Stress: Volume II | Ana Cipak Gasparovic Gabriella Spengler
Milica Pešić | 16 August 2021 |
| Biomedicines | Bioinformatics and Its Application in Biomedicine | Thomas Mohr | 31 July 2021 |
| Brain Sciences | At the Frontiers of Human Glioblastoma: Challenges in Introducing New Therapeutic Strategies | Milica Pešić Pilar Sánchez Gómez Lisa Oliver
| 15 June 2021 |
| Molecules | In Silico Activity Profiling of Natural Products | Ilza Pajeva
Mattia Mori | 15 May 2021 |
| Frontiers | The role of drug resistance mechanisms in tumor adaptation to oxidative stress | Ana Cipak Gasparovic Gabriella Spengler
Milica Pešić | 23 January 2021 |
| Pharmaceutics | Mitochondria-targeted drug delivery | Joanna Kopecka | 20 October 2020 |
| Cancers | The impact of extracellular vesicles in cancer progression and diagnosis | M. Helena Vasconcelos | 15 October 2020 |
| Anti-Oxidants | NO-donors with antioxidant activities and anticancer drugs | Loretta Lazzarato
Chiara Riganti | 31 July 2020 |
| Molecules | Design of natural products lead molecules using organic synthesis | Patrícia Rijo
Vera Isca | 31 July 2020 |
| International Journal of Molecular Sciences | New strategies to overcome resistance to chemotherapy and immune system in cancer | Chiara Riganti
Marialessandra Contino | 31 May 2020 (postponed deadline is fine!) |
| Cancer Drug Resistance | New challenges in overcoming chemoresistance in glioblastoma | Chiara Riganti
Joanna Kopecka | 30 April 2020 |
| Molecules | Phenotypic drug discovery | José M. Padrón | 31 March 2020 |
| Molecules | Breakthroughs in drug discovery and delivery in oncology | Flavio Rizzolio
Tiziano Tuccinardi | 29 February 2020 |
| Pharmaceutics | Biocompatible materials in drug delivery system in oncology | Flavio Rizzolio
Isabella Caligiuri | 29 February 2020 |
| Cancers | Cancer organoids in basic science and translational medicine | Flavio Rizzolio
Vincenzo Canzonieri
Lorenzo Memeo | 29 February 2020 |
